Notably, increased proliferation in pancreatic cancer cells is associated with TFEB overactivation, providing an excess of nutrients obtained by the glycogen synthase kinase-3 (GSK3) inhibitors [17]. The gene discussed is TFEB; the disease is familial pancreatic carcinoma.